Cargando…
The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations
Hotspot mutations in the core promoter region of the telomerase reverse transcriptase (TERT) gene have been well established to associate with aggressive clinical characteristics, radioiodine refractory, tumor recurrence, and mortality in thyroid cancer. Several E-twenty-six (ETS) transcription fact...
Autores principales: | Xue, Junyu, Li, Shiyong, Shi, Peijie, Chen, Mengke, Yu, Shuang, Hong, Shubin, Li, Yanbing, Liu, Rengyun, Xiao, Haipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242932/ https://www.ncbi.nlm.nih.gov/pubmed/34221969 http://dx.doi.org/10.3389/fonc.2021.649323 |
Ejemplares similares
-
The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer
por: Yu, Lin, et al.
Publicado: (2017) -
Selenite Induces Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species-Dependent Inhibition of the AKT/mTOR Pathway in Thyroid Cancer
por: Cheng, Zhen, et al.
Publicado: (2021) -
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
por: Barber-Rotenberg, Julie S., et al.
Publicado: (2012) -
YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
por: Rahim, Said, et al.
Publicado: (2011) -
Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer
por: Chen, Mengke, et al.
Publicado: (2023)